Review Article
Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update
Table 2
The characteristics and categories of EVs.
| | Characteristic | Exosomes | Microvesicles | Apoptotic bodies |
| | Apoptotic bodies | 50–150 | 100–1000 | 500–2000 | | Origin | Multivesicular body exocytosis | Cell membrane budding and fission | Plasma membrane, endoplasmic reticulum | | Morphology | Cup/round shaped | Various shapes | Heterogeneous | | Sucrose gradient | 1.13–1.19 g/mL | 1.04–1.07 g/mL | 1.16–1.28 g/mL | | Surface markers | Annexins, tetraspanins, heat-shock proteins | CD40, cholesterol, sphingomyelin, ceramide | Annexin V positivity, TSP, C3b | | Contents | Proteins, nucleic acids, lipid | Proteins, nucleic acids, lipid | Nuclear fractions, DNA, cell organelles | | Isolation technique | Centrifugation at 100,000 gravity | Ultracentrifugation | Ultracentrifugation |
|
|